reference/27456983

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27456983

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	21
issn	0167-8140
issueIdentifier	1
pageRange	18-21
publicationName	Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
startingPage	18
bibliographicCitation	Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J, Bliss J, Yarnold J. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol. 2005 Apr;75(1):18–21. doi: 10.1016/j.radonc.2004.12.012. PMID: 15878096.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7957-7424 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6554-5907 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a225ab28032de88ba6520f1cfce1dc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f034d10cefce28f197092f903efd0693 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f47b10b59af2ba3f04e7321cafc36139 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4fdc3d9fbe5bef0a08baaafd80fa98c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88e0c4ae1f557ef9cde64fc8cccd54be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3474904ffe621ad984b000d5f78957c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57978f9bc1a0a2800f38c490cf07e52c http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2103-005X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eface0970af25a70948b75ecfd095def http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bff6c09808bdd5423156f038541c11d
date	200504
identifier	https://doi.org/10.1016/j.radonc.2004.12.012 https://pubmed.ncbi.nlm.nih.gov/15878096
isPartOf	https://portal.issn.org/resource/ISSN/0167-8140 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6944
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer
discusses	http://id.nlm.nih.gov/mesh/M0024757 http://id.nlm.nih.gov/mesh/M0024760 http://id.nlm.nih.gov/mesh/M0004703 http://id.nlm.nih.gov/mesh/M0496359
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000532 http://id.nlm.nih.gov/mesh/D001943Q000235 http://id.nlm.nih.gov/mesh/D011832Q000209 http://id.nlm.nih.gov/mesh/D020641 http://id.nlm.nih.gov/mesh/D011832Q000235 http://id.nlm.nih.gov/mesh/D016212Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D011836Q000235 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D053773 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D003062 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013997
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4101f7063ae53d6af978fe9fd78f0ec7 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_12e4ad17b519957c896314136fc6daa3 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4d10109cd13a4d21cdae0406b2417f96 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dde3bf4279d96ccee1d6f267117b55e4

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7040 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7517 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7515 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6648 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID328 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID472

Total number of triples: 61.